Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 49 EP540 | DOI: 10.1530/endoabs.49.EP540

1Grodno State Medical University, Grodno, Belarus, 2Belarus State Medical University, Minsk, Belarus.


Objective: To determine the effects of hypoglycemia while sleeping on somnological parameters for patients with type 1 DM.

Materials and methods: The study included 57 person with type 1 DM (Group 1 – patients with blood glucose levels (BGL) during sleep <3.9 mmol/l; Group 2 – Patients with BGL – from 3.9 to 10.0 mmol/l. The examination included: daily monitoring of blood glucose by ‘CGMSGold’ (‘MedtronikMINIMED’ (USA)), polysomnography «SOMNOlab2 (PSG) Polysomnography (R & K)», the definition of HbA1c.

Results: Table

IndicatorGroup 1 n=14 Me [25;75]Group 2 n=43 Me [25;75]
BGL during sleeptime (mmol/l)02.35[2.00;3.10]*6.10[4.10;7.50]
Hypoglycemia «before sleep» (%)7.00[3.00;27.00]*5.23[0.00;5.00]
HBA1c (%)7.00[6.00;8.10]7.67[6.40;9.00]
Total sleep time (TST) (h)6.24[5.40;7.10]*5.30[4.51;6.20]
REM (%)39.50[26.00;48.00]*29.70[23.00;45.80]
N1(%)14.11[10.60;23.00]*8.80[4.70;14.30]
N2(%)38.8[35.20;61.40]48.20[34.00;53.30]
N3(%)3.00[1.20;6.10]3.44[2.30;6.30]
N4(%)1.45[0.00;2.89]*3.00[1.00;8.40]
*P<0.05.

Discussion and conclusions: For patients of Group 2 marked shortening of TST – 5.30 [4.51; 6.20] hours vs 6.24 [5.40; 7.10] hours (P=0.0219). Night hypoglycemia extend REM-sleep (39.50 [26.00; 48.00]% vs 29.70 [23.00; 45.80]% in the comparison group (P=0.0479), N1 sleep stage (14.11 [10.60; 23.00]% vs8.80 [4.70; 14.30]% (P=0.0110), as well as reduce the N4 stage of sleep (1.45 [0.00; 2.89]% vs 23.00 [1.00; 8.40]%). The share of hypoglycemia ‘before sleep’ extends N1 (r=0.5442); an increase in the length of N1 leads to a reduction in the duration of the deep stages of slow-wave sleep N3 (r=−0.6835), N4 (r=−0.5673); an increase in the duration of REM reduces N3 (r=−0.5887).

Conclusion: Hypoglycemia during sleep lengthens REM-sleep, REM sleep so reduces glycemia, providing interactive effects relative to each other, helping to increase the N1 and reduction of deep sleep stage (N3 and N4).

Volume 49

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.